These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1034 related items for PubMed ID: 19920783

  • 1. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD.
    Transplantation; 2009 Sep 27; 88(6):826-34. PubMed ID: 19920783
    [Abstract] [Full Text] [Related]

  • 2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep 27; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 3. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May 27; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 4. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era.
    Ravaioli M, Grazi GL, Ercolani G, Cescon M, Del Gaudio M, Zanello M, Ballardini G, Varotti G, Vetrone G, Tuci F, Lauro A, Ramacciato G, Pinna AD.
    Transplantation; 2006 Feb 27; 81(4):525-30. PubMed ID: 16495798
    [Abstract] [Full Text] [Related]

  • 5. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M, Masetti M, Dazzi A, Romano A, Spaggiari M, Grazi GL, Ercolani G, Cescon M, Di Gioia P, De Ruvo N, Montalti R, Ballarin R, Di Benedetto F, Ridolfi L, Alvaro N, Ramacciato G, Morelli C, Gerunda E, Pinna AD.
    Transplant Proc; 2008 Feb 27; 40(6):1814-5. PubMed ID: 18675057
    [Abstract] [Full Text] [Related]

  • 6. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL, Macedo FI, Miranda LE, Fernandes JL, da Silva CM, Neto OL, Lacerda CM.
    Transplant Proc; 2010 Mar 27; 42(2):407-11. PubMed ID: 20304152
    [Abstract] [Full Text] [Related]

  • 7. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN, Perkins JD, Carithers RL.
    Gastroenterology; 2008 May 27; 134(5):1342-51. PubMed ID: 18471511
    [Abstract] [Full Text] [Related]

  • 8. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 May 27; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 9. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA.
    Transpl Int; 2006 Apr 27; 19(4):275-81. PubMed ID: 16573542
    [Abstract] [Full Text] [Related]

  • 10. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G, Andorno E, Morelli N, Casaccia M, Bottino G, Ghirelli R, Valente U.
    Transplant Proc; 2008 Apr 27; 40(6):1903-5. PubMed ID: 18675084
    [Abstract] [Full Text] [Related]

  • 11. Change in model for end-stage liver disease score on the transplant waiting list predicts survival in patients undergoing liver transplantation.
    Foxton MR, Kendrick S, Sizer E, Muiesan P, Rela M, Wendon J, Heaton ND, O'Grady JG, Heneghan MA.
    Transpl Int; 2006 Dec 27; 19(12):988-94. PubMed ID: 17081228
    [Abstract] [Full Text] [Related]

  • 12. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group.
    J Hepatol; 2014 Feb 27; 60(2):290-7. PubMed ID: 24161408
    [Abstract] [Full Text] [Related]

  • 13. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 27; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 14. Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.
    Moonka D, Castillo E, Kumer S, Abouljoud M, Divine G, Pelletier S.
    Transplant Proc; 2009 Jul 27; 41(1):216-8. PubMed ID: 19249517
    [Abstract] [Full Text] [Related]

  • 15. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
    Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R, Nakache R.
    Isr Med Assoc J; 2006 Sep 27; 8(9):605-9. PubMed ID: 17058408
    [Abstract] [Full Text] [Related]

  • 16. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ, Negm A, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP.
    Transpl Int; 2009 Oct 27; 22(10):970-8. PubMed ID: 19619170
    [Abstract] [Full Text] [Related]

  • 17. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L.
    Liver Transpl; 2007 Jun 27; 13(6):857-66. PubMed ID: 17539006
    [Abstract] [Full Text] [Related]

  • 18. Greater travel time to a liver transplant center does not adversely affect clinical outcomes.
    Firozvi AA, Lee CH, Hayashi PH.
    Liver Transpl; 2008 Jan 27; 14(1):18-24. PubMed ID: 18161800
    [Abstract] [Full Text] [Related]

  • 19. Live donor liver transplantation in high MELD score recipients.
    Selzner M, Kashfi A, Cattral MS, Selzner N, McGilvray ID, Greig PD, Levy GA, Renner EL, Grant DR.
    Ann Surg; 2010 Jan 27; 251(1):153-7. PubMed ID: 19858705
    [Abstract] [Full Text] [Related]

  • 20. A new liver transplant priority for patients with hepatocellular carcinoma.
    Ravaioli M, Grazi GL, Vetrone G, Kimura T, Zanello M, Ercolani G, Cescon M, Varotti G, Del Gaudio M, Tuci F, Cucchetti A, La Barba G, Vivarelli M, Lauro A, Ramacciato G, Pinna AD.
    Hepatogastroenterology; 2008 Jan 27; 55(86-87):1742-5. PubMed ID: 19102382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.